CLINICAL_TRIALS
trial_result
· 2017-03-31
Clinical Trial Update: The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study [Phase 2]
Summary
The READ-2 Phase 2 trial evaluated ranibizumab for diabetic macular edema; the study has completed and results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2017-03-31